Plunkett Research Online: Lescarden Inc

LESCARDEN INC (LCAR:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Lescarden, Inc. funds research and development of proprietary biologic materials with a focus on wound healing, skin care, osteoarthritis and cancer applications. Significant studies have substantiated the ability of Catrix, Lescarden's proprietary cartilage powder, to function as a biological respo.....



Lescarden Inc
Ticker: LCAR
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 212 687-1050
Fax: 212 687-1051
Address: 420 Lexington Avenue
Suite 212
New York, NY 10170 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Wound Healing Products
ContactsDescription
William LutherCEO/CFO/Chief Accounting Officer/Director/President
Xavier BalaguerDirector
See More
Lescarden, Inc. funds research and development of proprietary biologic materials with a focus on wound healing, skin care, osteoarthritis and cancer applications. Significant studies have substantiated the ability of Catrix, Lescarden's proprietary cartilage powder, to function as a biological respo.....See More See More

Auditor: Cowan, Gunteski & Co., P.A.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: